TY - JOUR
T1 - Process evaluation of a tailored work-related support intervention for patients diagnosed with gastrointestinal cancer
AU - Zaman, AnneClaire G. N. M.
AU - Tytgat, Kristien M. A. J.
AU - Klinkenbijl, Jean H. G.
AU - de Boer, Angela G. E. M.
AU - Frings-Dresen, Monique H. W.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Purpose: To perform a process evaluation of a tailored work-related support intervention for patients diagnosed with gastrointestinal cancer. Methods: The intervention comprised three tailored psychosocial work-related support meetings. To outline the process evaluation of this intervention, we used six key components: recruitment, context, reach, dose delivered, dose received and fidelity. Data were collected using questionnaires, checklists and research logbooks and were analysed both quantitatively and qualitatively. Results: In total, 16 hospitals, 33 nurses and 7 oncological occupational physicians (OOPs) participated. Analysis of the six key components revealed that the inclusion rate of eligible patients was 47%. Thirty-eight intervention patients were included: 35 actually had a first meeting, 32 had a second and 17 had a third. For 31 patients (89%), the first meeting was face to face, as per protocol. However, in only 32% of the cases referred to support type A (oncological nurse) and 13% of the cases referred to support type B (OOP), the first meeting was before the start of the treatment, as per protocol. The average duration of the support type A meetings was around the pre-established 30 min; for the OOPs, the average was 50 min. Protocol was easy to follow according to the healthcare professionals. Overall, the patients considered the intervention useful. Conclusions: This study has shown that the strategy of tailored work-related support is appreciated by both patients and healthcare professionals and applicable in clinical practice. Implications for Cancer survivors: The intervention was appreciated by patients; however, whether the timing of the work-related support was adequate (i.e. before treatment was started) requires further research. Trial registration: NTR5022.
AB - Purpose: To perform a process evaluation of a tailored work-related support intervention for patients diagnosed with gastrointestinal cancer. Methods: The intervention comprised three tailored psychosocial work-related support meetings. To outline the process evaluation of this intervention, we used six key components: recruitment, context, reach, dose delivered, dose received and fidelity. Data were collected using questionnaires, checklists and research logbooks and were analysed both quantitatively and qualitatively. Results: In total, 16 hospitals, 33 nurses and 7 oncological occupational physicians (OOPs) participated. Analysis of the six key components revealed that the inclusion rate of eligible patients was 47%. Thirty-eight intervention patients were included: 35 actually had a first meeting, 32 had a second and 17 had a third. For 31 patients (89%), the first meeting was face to face, as per protocol. However, in only 32% of the cases referred to support type A (oncological nurse) and 13% of the cases referred to support type B (OOP), the first meeting was before the start of the treatment, as per protocol. The average duration of the support type A meetings was around the pre-established 30 min; for the OOPs, the average was 50 min. Protocol was easy to follow according to the healthcare professionals. Overall, the patients considered the intervention useful. Conclusions: This study has shown that the strategy of tailored work-related support is appreciated by both patients and healthcare professionals and applicable in clinical practice. Implications for Cancer survivors: The intervention was appreciated by patients; however, whether the timing of the work-related support was adequate (i.e. before treatment was started) requires further research. Trial registration: NTR5022.
KW - Gastrointestinal neoplasms
KW - Patient care
KW - Process evaluation
KW - Return to work
KW - Vocational rehabilitation
UR - http://www.scopus.com/inward/record.url?scp=85075394779&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s11764-019-00797-3
DO - https://doi.org/10.1007/s11764-019-00797-3
M3 - Article
C2 - 31745819
SN - 1932-2259
VL - 14
SP - 59
EP - 71
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 1
ER -